Li, Bo http://orcid.org/0000-0003-0668-1620
Gould, Joshua http://orcid.org/0000-0001-9581-5461
Yang, Yiming http://orcid.org/0000-0002-0386-9428
Sarkizova, Siranush
Tabaka, Marcin
Ashenberg, Orr
Rosen, Yanay
Slyper, Michal
Kowalczyk, Monika S.
Villani, Alexandra-ChloƩ
Tickle, Timothy
Hacohen, Nir http://orcid.org/0000-0002-2349-2656
Rozenblatt-Rosen, Orit http://orcid.org/0000-0001-6313-3570
Regev, Aviv http://orcid.org/0000-0003-3293-3158
Funding for this research was provided by:
Howard Hughes Medical Institute
Article History
Received: 29 October 2019
Accepted: 18 June 2020
First Online: 27 July 2020
Competing interests
: A.R. is a founder of and equity holder in Celsius Therapeutics, a Scientific Advisory Board member of Thermo Fisher Scientific, Neogene Therapeutics, Syros Pharamceuticals and Asimov, and an equity holder in Immunitas. N.H. is a founder and Scientific Advisory Board member of Neon Therapeutics. A.R. is a co-inventor on patent applications filed by the Broad Institute to inventions relating to single-cell genomics.